RecruitingPhase 4NCT06972056
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Sponsor: Mayo Clinic
Kingston, NY · Manhasset, NY · New York, NY · +34 more sites
Migraine clinical trials in New York, NY
11 recruiting migraine studies with a site in New York, NY.
RecruitingPhase 3NCT07674654
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Amherst, NY · Brooklyn, NY · Commack, NY · +110 more sites
RecruitingNot applicableNCT06077838
RELAXaHEAD for Headache Patients (Phase III)
Sponsor: NYU Langone Health
New York, NY
RecruitingPhase 3NCT07629635
Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy
Sponsor: Columbia University
New York, NY
RecruitingPhase 3NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Amherst, NY · New York, NY · +40 more sites
RecruitingNot applicableNCT06735833
MMA Embolization for Refractory Chronic Migraine
Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Buffalo, NY · New York, NY · Stony Brook, NY · +5 more sites
RecruitingPhase 3NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sponsor: Pfizer
Amherst, NY · Commack, NY · Great Neck, NY · +166 more sites
RecruitingPhase 3NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sponsor: Pfizer
Amherst, NY · Commack, NY · New York, NY · +112 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Amherst, NY · Mount Kisco, NY · New York, NY · +122 more sites
RecruitingPhase 3NCT07645924
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Amherst, NY · Brooklyn, NY · Commack, NY · +110 more sites
RecruitingPhase 2NCT06602479
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Sponsor: AbbVie
New York, NY · +15 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.